Macroporous 3-D scaffolds for tissue engineering
View Patent ↗Macroporous 3-D tissue engineering scaffold comprising elastomeric cross-linked polymer units and interconnected macropores containing living cells are produced by step of: in a mixture of the cells and elastomeric polymer units comprising activatable crosslinking groups, activating the crosslinking groups to form the scaffold.
1. A method of making microribbons, the method comprising:
wet-spinning a solution comprising a first multi-armed synthetic polymer comprising N-hydroxysuccinimide ester (“NHS ester”) end groups and methacrylate (“MA”) end groups and a second multi-armed synthetic polymer comprising NHS ester end groups and hydroxyl (OH) end groups into a bath comprising an anti-solvent and tris(2-aminoethyl)amine (“TAEA”), whereby the shear force of the stirring flow initiates a crosslinking reaction between various amine groups of the TAEA and various NHS ester end groups of the first multi-armed synthetic polymer and the second multi-armed synthetic polymer, yielding the microribbons.
2. The method of claim 1 , wherein the molecular structure of the first multi-armed synthetic polymer includes a polymer selected from the group consisting of poly(ethylene glycol), poly(lactic-co-glycolic acid), poly(glycolic acid), poly(lactic acid), polycaprolactone, and poly(methyl methacrylate).
3. The method of claim 1 , wherein the molecular structure of the second multi-armed synthetic polymer includes a polymer selected from the group consisting of poly(ethylene glycol), poly(lactic-co-glycolic acid), poly(glycolic acid), poly(lactic acid), polycaprolactone, and poly(methyl methacrylate).
4. The method of claim 2 , wherein the molecular structure of the second multi-armed synthetic polymer includes a polymer selected from the group consisting of poly(ethylene glycol), poly(lactic-co-glycolic acid), poly(glycolic acid), poly(lactic acid), polycaprolactone, and poly(methyl methacrylate).
5. The method of claim 1 , wherein the first multi-armed synthetic polymer is an eight-armed poly(ethylene glycol) (“PEG”) having the following formula: PEG-(NHS ester) 4 -(MA) 4 .
6. The method of claim 1 , wherein the second multi-armed synthetic polymer is an eight-armed poly(ethylene glycol) (“PEG”) having the following formula: PEG-(NHS ester) 4 -(OH) 4 .
7. The method of claim 5 , wherein the second multi-armed synthetic polymer is an eight-armed poly(ethylene glycol) (“PEG”) having the following formula: PEG-(NHS ester) 4 -(OH) 4 .
8. A method of making a three-dimensional (3D) tissue engineering scaffold, the method comprising:
wet-spinning a solution comprising a first multi-armed synthetic polymer comprising N-hydroxysuccinimide ester (“NHS ester”) end groups and methacrylate (“MA”) end groups and a second multi-armed synthetic polymer comprising NHS ester end groups and hydroxyl (OH) end groups into a bath comprising an anti-solvent and tris(2-aminoethyl)amine (“TAEA”), whereby the shear force of the stirring flow initiates a crosslinking reaction between various amine groups of the TAEA and various NHS ester end groups of the first multi-armed synthetic polymer and the second multi-armed synthetic polymer, yielding microribbons;
suspending the microribbons in a liquid;
adding a photoinitiator to the liquid;
irradiating the liquid with light sufficient to initiate a photocrosslinking reaction between various MA end groups, thereby yielding the 3D tissue engineering scaffold.
9. The method of claim 8 , further comprising suspending living cells in the liquid, before irradiating the liquid with light sufficient to initiate the photocrosslinking reaction.
10. The method of claim 9 , wherein the living cells are stem cells.
11. The method of claim 8 , wherein the liquid is phosphate-buffered saline.
12. The method of claim 8 , wherein the photoinitiator is lithium phenyl-2,4,6-trimethylbenzoylphosphinate.
13. The method of claim 8 , further comprising coating the microribbons with an additional amount of the first multi-armed synthetic polymer comprising N-hydroxysuccinimide ester (“NHS ester”) end groups and methacrylate (“MA”) end groups, before suspending the microribbons in the liquid.
14. The method of claim 8 , further comprising coating the microribbons with a third multi-armed synthetic polymer comprising maleimide end groups, before suspending the microribbons in the liquid.
15. The method of claim 14 , further comprising covalently bonding molecules of a thiolated bioactive ligand to various maleimide end groups of the coating via thiol-ene addition.
16. The method of claim 15 , wherein the thiolated bioactive ligand is a protein or peptide.
17. The method of claim 8 , wherein the molecular structure of the first multi-armed synthetic polymer includes a polymer selected from the group consisting of poly(ethylene glycol), poly(lactic-co-glycolic acid), poly(glycolic acid), poly(lactic acid), polycaprolactone, and poly(methyl methacrylate).
18. The method of claim 8 , wherein the molecular structure of the second multi-armed synthetic polymer includes a polymer selected from the group consisting of poly(ethylene glycol), poly(lactic-co-glycolic acid), poly(glycolic acid), poly(lactic acid), polycaprolactone, and poly(methyl methacrylate).
19. The method of claim 8 , wherein the first multi-armed synthetic polymer is an eight-armed poly(ethylene glycol) (“PEG”) having the following formula: PEG-(NHS ester) 4 -(MA) 4 .
20. The method of claim 8 , wherein the second multi-armed synthetic polymer is an eight-armed poly(ethylene glycol) (“PEG”) having the following formula: PEG-(NHS ester) 4 -(OH) 4 .